Story perspectives

Cambridge AI-Designed COVID Vaccine Enters First Human Trial

6/5/2026

Summary

Story summary

University of Cambridge researchers gave the first AI-designed coronavirus vaccine to 39 volunteers, marking the first human trial of an antigen created solely by artificial intelligence.
The team is monitoring safety outcomes for the participants as the trial proceeds.
Prof Jonathan Heeney said the approach aims to protect against all current and future coronavirus strains.
A follow-up study with about 200 volunteers will assess the strength of the immune response.

1 of 1

Story summary

University of Cambridge researchers gave the first AI-designed coronavirus vaccine to 39 volunteers, marking the first human trial of an antigen created solely by artificial intelligence.
The team is monitoring safety outcomes for the participants as the trial proceeds.
Prof Jonathan Heeney said the approach aims to protect against all current and future coronavirus strains.
A follow-up study with about 200 volunteers will assess the strength of the immune response.